|
Mutation Information
|
Mutation Site
|
V370D |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
Gag |
|
Relevant Drug
|
bevirimat |
Literature Information
|
PubMed PMID
|
27090171
|
|
Published Year
|
2016 |
|
Journal
|
Antimicrobial agents and chemotherapy |
|
Title
|
Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage. |
|
Author
|
Nowicka-Sans B,Protack T,Lin Z,Li Z,Zhang S,Sun Y,Samanta H,Terry B,Liu Z,Chen Y,Sin N,Sit SY,Swidorski JJ,Chen J,Venables BL,Healy M,Meanwell NA,Cockett M,Hanumegowda U,Regueiro-Ren A,Krystal M,Dicker IB |
|
Evidence
|
Site-directed polymorphic changes in Gag that reduce susceptibility to bevirimat (including V362I, V370A/M/Delta, and T371A/Delta), leading incrementally to the identification of BMS-955176.
|
|
|